Table 1. Activity and efficacy in elderly MCRC patients.
| FIr-B/FOx | FOLFOXIRI | FOLFIRI | |
|---|---|---|---|
| Enrolled patients, No. | 28 | 75 | 82 |
| Objective Response, % | 79 | 32 | 34 |
| Median progression-free survival, months | 11 | 8.5 | 6.2 |
| Median overall survival, months | 21 | 19.9 | 17.8 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.